Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.

Campbell IA, Douglas JG, Francis RM, Prescott RJ, Reid DM; Research Committee of the British Thoracic Society.

Thorax. 2004 Sep;59(9):761-8.

2.
3.

Bisphosphonates for steroid-induced osteoporosis.

Allen CS, Yeung JH, Vandermeer B, Homik J.

Cochrane Database Syst Rev. 2016 Oct 5;10:CD001347. Review.

PMID:
27706804
5.

Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003376. doi: 10.1002/14651858.CD003376.pub3. Review.

PMID:
18254018
6.

Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.

Avenell A, Mak JC, O'Connell D.

Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227. doi: 10.1002/14651858.CD000227.pub4. Review.

PMID:
24729336
7.

Etidronate and alendronate in the treatment of postmenopausal osteoporosis.

Beauchesne MF, Miller PF.

Ann Pharmacother. 1999 May;33(5):587-99. Review.

PMID:
10369624
8.

Etridronate therapy in the treatment and prevention of osteoporosis.

Hanley DA, Ioannidis G, Adachi JD.

J Clin Densitom. 2000 Spring;3(1):79-95. Review.

PMID:
10745305
9.

WITHDRAWN: Etidronate for treating and preventing postmenopausal osteoporosis.

Cranney A, Adachi JD, Griffith L, Guyatt G, Krolicki N, Robinson VA, Shea BJ, Wells G.

Cochrane Database Syst Rev. 2007 Jul 18;(1):CD003376. Review.

PMID:
17636719
10.

Osteoporosis: trials and tribulations.

Seeman E.

Am J Med. 1997 Aug 18;103(2A):74S-87S; discussion 87S-89S. Review.

PMID:
9302899
11.

Etidronate for treating and preventing postmenopausal osteoporosis.

Cranney A, Welch V, Adachi JD, Guyatt G, Krolicki N, Griffith L, Shea B, Tugwell P, Wells G.

Cochrane Database Syst Rev. 2001;(4):CD003376. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD003376. Cochrane Database Syst Rev. 2008;(1):CD003376.

PMID:
11687195
12.

Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.

Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Lévesque LE, Adachi JD, Cadarette SM.

Osteoporos Int. 2016 May;27(5):1709-18. doi: 10.1007/s00198-015-3455-9. Epub 2015 Dec 22. Review.

PMID:
26694595
13.

Efficacy of oral etidronate for skeletal diseases in Japan.

Iwamoto J, Takeda T, Sato Y.

Yonsei Med J. 2005 Jun 30;46(3):313-20. Review.

14.

Present and future of osteoporosis therapy.

Seeman E, Tsalamandris C, Bass S, Pearce G.

Bone. 1995 Aug;17(2 Suppl):23S-29S. Review.

PMID:
8579894
15.

The Skeletal Effects of Inhaled Glucocorticoids.

Sutter SA, Stein EM.

Curr Osteoporos Rep. 2016 Jun;14(3):106-13. doi: 10.1007/s11914-016-0308-1. Review.

Supplemental Content

Support Center